Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease

Emily Henkle, Kevin L. Winthrop, Gregory P. Ranches, Wesley Plinke, Hana K. Litvin, Alexandra L. Quittner

Source: Eur Respir J, 55 (1) 1901300; 10.1183/13993003.01300-2019
Journal Issue: January
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Emily Henkle, Kevin L. Winthrop, Gregory P. Ranches, Wesley Plinke, Hana K. Litvin, Alexandra L. Quittner. Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease. Eur Respir J, 55 (1) 1901300; 10.1183/13993003.01300-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Patient reported outcomes for non-tuberculous mycobacterial disease
Source: Eur Respir J, 55 (1) 1902204; 10.1183/13993003.02204-2019
Year: 2020



Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020


Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
Source: Eur Respir J, 51 (3) 1800170; 10.1183/13993003.00170-2018
Year: 2018



Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease
Source: Eur Respir J, 53 (5) 1801636; 10.1183/13993003.01636-2018
Year: 2019



Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases
Source: Eur Respir J 2001; 18: Suppl. 33, 443s
Year: 2001

Comparative study of clinical features between elderly and non-elderly patients with pulmonary nontuberculous mycobacterial disease
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021


Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Source: Guideline 2020
Year: 2020

Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020
Year: 2020



Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Characteristics of patients with pulmonary non-tuberculous Mycobacterial infection in bronchiectasis: Data from the EMBARC registry
Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Year: 2018


The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease
Source: Eur Respir Monogr 2018; 81: 204-221
Year: 2018


Impact of pulmonary tuberculosis on COPD outcomes
Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease
Year: 2021



Clinical profile and outcome of complicated pulmonary tuberculosis in children
Source: Eur Respir J 2002; 20: Suppl. 38, 362s
Year: 2002

Evaluation of non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis: Interim analysis of a TBNET study
Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2012


Clinical features of respiratory nontuberculous mycobacteria – a four-year comparison by immunosuppression status
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019